CSPC Pharmaceutical Group (XTER:CVG) Other Long Term Assets : €701 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is CSPC Pharmaceutical Group Other Long Term Assets?

CSPC Pharmaceutical Group's other long-term assets for the quarter that ended in Dec. 2023 was €701 Mil.

CSPC Pharmaceutical Group's quarterly other long-term assets declined from Jun. 2023 (€700 Mil) to Sep. 2023 (€0 Mil) but then increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€701 Mil).

CSPC Pharmaceutical Group's annual other long-term assets increased from Dec. 2021 (€587 Mil) to Dec. 2022 (€635 Mil) and increased from Dec. 2022 (€635 Mil) to Dec. 2023 (€701 Mil).

CSPC Pharmaceutical Group Other Long Term Assets Historical Data

The historical data trend for CSPC Pharmaceutical Group's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Other Long Term Assets Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

258.49

572.67

586.82

635.41

701.33

CSPC Pharmaceutical Group Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															635.41	-	700.32	-	701.33

CSPC Pharmaceutical Group Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

CSPC Pharmaceutical Group (XTER:CVG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (XTER:CVG) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA 01093:Hong Kong CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.